Komori
Governance4882Perseus Proteomics Inc.Pharmaceuticals

Independent Officer Notification Form

Following the resolution of the proposal to elect outside directors at the annual general meeting of shareholders, the company submitted an Independent Officer Notification Form. All 5 outside directors were reported as independent officers, including 2 newly appointed directors, Matsumoto Hisashi (松本尚) and Nishigaki Fusako (西垣扶佐子).

Worth reading
—
Scored from 0 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
5
Independent officers (outside directors)
Wording
Definitive
How definitive the wording is.

Governance structure

Number of directors5 outside directors (total number of directors: Not disclosed)
Number of independent officers5Number

This is the number of people reported to the exchange as independent officers. Whether someone is an outside officer and whether they qualify as independent are separate determinations.

Changes this time

The proposal to elect outside directors was resolved at the annual general meeting of shareholders, and Matsumoto Hisashi (松本尚) and Nishigaki Fusako (西垣扶佐子) were newly appointed. All 5 outside directors have been designated as independent officers.

Governance structure
ItemDetails
Number of directors5 outside directors (total number of directors: Not disclosed)
Number of independent officers5
Changes this timeThe proposal to elect outside directors was resolved at the annual general meeting of shareholders, and Matsumoto Hisashi (松本尚) and Nishigaki Fusako (西垣扶佐子) were newly appointed. All 5 outside directors have been designated as independent officers.
Items this document does not state (5)
Corporate Governance StructureCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because the proposal to elect outside directors was resolved at the annual general meeting of shareholders.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Independent Officer Notification Form | Perseus Proteomics Inc. (4882) timely disclosure | Komori